Skip to main content

Table 2 Research hypotheses and verification

From: Determinants of the willingness to participate in biobanking among Malaysian stakeholders in the Klang Valley

Research hypothesis Conclusion
H1 (Engagement ➔ Perceived benefits) When stakeholders are more engaged with modern biotechnology, then they will perceive higher benefits associated with biobanks. Supported
H2 (Engagement ➔ Issues of data & specimen protection) When stakeholders are more engaged with biotechnology, then they will exhibit less concern regarding issues of data and specimen protection in biobanks. Not Supported
H3 (Engagement ➔ Religious acceptance) When stakeholders are more engaged with biotechnology, then they will be more accepting of biobanks from a religious perspective. Supported
H4 (Engagement ➔ Willingness to participate) When stakeholders are more engaged with biotechnology, then they will be more willing to participate in biobanking. Not Supported
H5 (Trust in key players ➔ Perceived benefits) When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will perceive stronger benefits associated with biobanks. Supported
H6 (Trust in key players ➔ Issues of data & specimen protection) When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will exhibit lower concerns regarding issues of data and specimen protection in biobanks. Not Supported
H7 (Trust in key players ➔ Religious acceptance) When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will be more accepting of biobanks from a religious perspective. Not Supported
H8 (Trust in key players ➔ Willingness to participate) When stakeholders have more trust in key players involved in using or regulating modern biotechnology, then they will be more willing to participate in biobanking. Supported
H9 (Attitude towards technology ➔ Issues of data & specimen protection) When stakeholders exhibit a strong negative predisposition towards science and technology, then they will exhibit stronger concerns regarding issues of data and specimen protection in biobanks. Supported
H10 (Attitude towards technology ➔ Religious acceptance) When stakeholders exhibit a strong negative predisposition towards science and technology, then they will be less accepting of biobanks from a religious perspective. Not Supported
H11 (Religiosity ➔ Perceived benefits) When stakeholders view themselves are more religious, then they will perceive stronger benefits associated with biobanks. Supported
H12 (Religiosity ➔ Issues of data & specimen protection) When stakeholders view themselves as more religious, then they will exhibit stronger concerns regarding issues of data and specimen protection in biobanks. Supported
H13 (Religiosity ➔ Willingness to participate) When stakeholders view themselves as more religious, then they will be more willing to participate in biobanking. Not Supported
H14 (Issues of data & specimen protection ➔ Perceived benefits) When stakeholders have strong concerns regarding issues of data and specimen protection associated with biobanks, then they will perceive fewer benefits associated with biobanks. Not Supported
H15 (Issues of data & specimen protection ➔ Religious acceptance) When stakeholders have stronger concerns regarding issues of data and specimen protection associated with biobanks, then they will be less accepting of biobanks from a religious perspective. Supported
H16 (Issues of data & specimen protection ➔ Willingness to participate) When stakeholders have strong concerns about issues of data and specimen protection associated with biobanks, then they will be less willing to participate in biobanking. Supported
H17 (Perceived benefits ➔ Religious acceptance) When stakeholders perceive stronger benefits associated with biobanks, then they will be more accepting of biobanks from a religious perspective. Supported
H18 (Perceived benefits ➔ Willingness to participate) When stakeholders perceive stronger benefits associated with biobanks, then they be more willing to participate in biobanking. Supported
H19 (Religious acceptance ➔ Willingness to participate) When stakeholders are more accepting of biobanks from a religious perspective, then they will be more willing to participate in biobanking. Supported